Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report
about
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancersCharacterization of DNA Methylation in Circulating Tumor CellsEpigenetic modulators as therapeutic targets in prostate cancerAn open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinomaDNA demethylating agent decitabine broadens the peripheral T cell receptor repertoire.Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries.Improving cancer immunotherapy with DNA methyltransferase inhibitors.Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression.
P2860
Q26743743-CDA19B45-398C-4C32-BD65-DE06D590027CQ26778427-24392CB2-83B8-416D-8644-8A49BED7086FQ28071912-D5A3B006-4551-4482-A797-81B588951662Q36140936-E8644BBE-FAFA-4420-A353-ACF920712715Q37437334-6AB9FE60-17D0-4453-ACA4-04EF94C390E5Q37645061-603B47A3-49C2-4451-BD7B-E9A74832E7A9Q38332497-01CC5F76-4E47-4897-A12A-9450E0FBA96FQ38662760-DEE208D1-E25B-4083-95E3-6D25E452F47DQ38854734-084AC5D8-3020-4B07-99F5-9811378916F6Q47109220-DC00D632-9787-42D2-80C1-03ED46089472Q52597632-929BDAB0-72AF-4043-A553-424E4A402208
P2860
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Low-dose decitabine-based chem ...... id tumors: a phase I/II report
@ast
Low-dose decitabine-based chem ...... id tumors: a phase I/II report
@en
type
label
Low-dose decitabine-based chem ...... id tumors: a phase I/II report
@ast
Low-dose decitabine-based chem ...... id tumors: a phase I/II report
@en
prefLabel
Low-dose decitabine-based chem ...... id tumors: a phase I/II report
@ast
Low-dose decitabine-based chem ...... id tumors: a phase I/II report
@en
P2093
P2860
P356
P1476
Low-dose decitabine-based chem ...... id tumors: a phase I/II report
@en
P2093
Fengxia Shi
Hongli Zhu
Kaichao Feng
Meixia Chen
Weidong Han
Wenying Zhang
Xiaobing Fu
P2860
P304
P356
10.1155/2014/371087
P577
2014-05-21T00:00:00Z